Dib-u-eegis ay qoreen Young, MD, Xarunta Kansarka ee Anderson, USA waxay sharraxday dalabka PD-1 inhibitor immunotherapy ee B-cell lymphoma. (Dhiig. Nooca khadka tooska ah Noofeembar 8, 2017. doi: 10.1182 / blood-2017-07-740993.) PD-1 difaaca ..
Isbitaalka Cleveland ee Mareykanka Eric D. His et al. Waxaa lagu soo warramay in ogaanshaha unugyada unugyada unugyada 'T cell lymphoma' (PTCL) ee ku yaal Mareykanka aad u kala duwan yihiin, badanaana aan lahayn macluumaad muhiim ah oo muhiim ah oo si buuxda loo kala sooco ..
Burooyinka qaangaarka ah ee T-cell, sida non-Hodgkin T-cell lymphoma, waa kuwo aad u kacsan oo u adkaysta daroogada, bukaanada badiyaa waxay leeyihiin saadaal xumo. Dhawaan, taxanaha "Dabeecadda" ee labo maqaal ayaa daabacay fasiraad cusub oo ku saabsan cudur-sidaha.
Cayilku ma aha oo kaliya liddi ku ah bilicda dadka, laakiin sidoo kale waxay keentaa cudurro badan oo dabadheeraad ah. Daraasadaha qaar ayaa muujiyay in index mass index (BMI) ay la xiriirto khatarta kansarka ee qaybo gaar ah (sida habka dheef-shiidka), ...
Shalay, FDA-da Mareykanka waxay ku dhawaaqday in la ansixiyay Seattle Genetics 'antibody-drug conjugate Adcetris (brentuximab vedotin) oo ay weheliso daaweynta kiimikada ee loogu talagalay bukaannada horey loogu daaweeyay heerka III ama IV-da' Hodgkin's lymph ..
Cilmi-baarista cusub ee Cleveland Clinic waxay muujineysaa markii ugu horreysay in FDA-ay ansixisay ibrutinib (ibrutinib) ee lymphoma iyo leukemia ay sidoo kale kaa caawin karto daweynta burooyinka ugu caansan uguna daran ee maskaxda, waxaana laga yaabaa in maalin uun loo isticmaalo bukaanada qaba gliobla ..
dhuuxa lafta fibrosis waa cudur naadir ah oo raaga oo ku dhaca unugyada hematopoietic dhuuxa lafta. Waxay ka faa'iideysteen dawooyinka ka hortagga JAK2: nasinta calaamadaha, badbaadada dheeraadka ah, iyo tayada nolosha oo soo hagaagtay. Si kastaba ha ahaatee, laba ama saddex sano ka dib bilowga.
Juun 12-13, FDA waxay ansixisay laba calaamadood oo cusub oo loogu talagalay daawada K, maalin uun ka hor intaan dawada K loo oggolaan daawaynta kansarka ilmo galeenka. Hal maalin ka dib, US FDA waxay ogolaatay pembrolizumab (Keytruda, pembrolizumab) ee trea.
Dalka Maraykanka, in ka badan 70,000 oo qof ayaa laga helaa lymphoma non-Hodgkin sanad kasta, taas oo ay sababto badinta xad-dhaafka ah ee unugyada difaaca ee qanjidhada jirka. Kan ugu caansan waa qanjidh weyn oo B-cell ah.
Sanadihii la soo dhaafay, saamaynta isbaarada difaaca ee daawaynta Hodgkin's lymfoma (HL) waa mid cajiib ah, laakiin cudurku wali wuxuu u baahan yahay in si fiican looga gudbo. Gudoomiyaha Kooxda Lymphoma ee Mayo Clinic Ansell sai..